AGL
Income statement / Annual
Last year (2025), Agilon Health Inc's total revenue was $5.93 B,
a decrease of 2.11% from the previous year.
In 2025, Agilon Health Inc's net income was -$405.35 M.
See Agilon Health Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$5.93 B |
$6.06 B |
$4.32 B |
$2.39 B |
$1.52 B |
$1.22 B |
$794.41 M |
| Cost of Revenue |
$6.12 B
|
$6.06 B
|
$4.25 B
|
$2.28 B
|
$1.46 B
|
$1.12 B
|
$765.90 M
|
| Gross Profit |
-$188.61 M
|
$4.84 M
|
$69.67 M
|
$111.36 M
|
$65.74 M
|
$94.15 M
|
$28.51 M
|
| Gross Profit Ratio |
-0.03
|
0
|
0.02
|
0.05
|
0.04
|
0.08
|
0.04
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$238.54 M
|
$268.91 M
|
$285.76 M
|
$207.79 M
|
$427.50 M
|
$137.29 M
|
$122.83 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$238.54 M
|
$268.91 M
|
$285.76 M
|
$207.79 M
|
$427.50 M
|
$137.29 M
|
$122.83 M
|
| Other Expenses |
-$6.08 M
|
$28.06 M
|
$16.04 M
|
$8.95 M
|
$10.48 M
|
$13.53 M
|
$12.25 M
|
| Operating Expenses |
$232.46 M
|
$296.97 M
|
$301.80 M
|
$216.74 M
|
$437.99 M
|
$150.82 M
|
$135.09 M
|
| Cost And Expenses |
$6.35 B
|
$6.35 B
|
$4.55 B
|
$2.49 B
|
$1.89 B
|
$1.28 B
|
$900.99 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$6.64 M
|
$6.18 M
|
$6.66 M
|
$4.48 M
|
$6.15 M
|
$8.14 M
|
$9.07 M
|
| Depreciation & Amortization |
$28.59 M
|
$24.46 M
|
$20.16 M
|
$13.77 M
|
$14.67 M
|
$14.10 M
|
$41.41 M
|
| EBITDA |
-$368.86 M |
-$218.19 M |
-$167.64 M |
-$72.41 M |
-$362.16 M |
-$40.11 M |
-$64.21 M |
| EBITDA Ratio |
-0.06
|
-0.04
|
-0.04
|
-0.03
|
-0.24
|
-0.03
|
-0.08
|
| Operating Income Ratio |
-0.07
|
-0.05
|
-0.05
|
-0.04
|
-0.24
|
-0.05
|
-0.13
|
| Total Other Income/Expenses Net |
$16.98 M
|
$43.30 M
|
$37.67 M
|
$14.71 M
|
-$10.73 M
|
-$5.67 M
|
-$8.11 M
|
| Income Before Tax |
-$404.10 M
|
-$248.83 M
|
-$194.46 M
|
-$90.67 M
|
-$382.98 M
|
-$62.34 M
|
-$114.69 M
|
| Income Before Tax Ratio |
-0.07
|
-0.04
|
-0.05
|
-0.04
|
-0.25
|
-0.05
|
-0.14
|
| Income Tax Expense |
$1.25 M
|
$1.45 M
|
$791.00 K
|
$1.64 M
|
$886.00 K
|
$865.00 K
|
-$232.00 K
|
| Net Income |
-$405.35 M
|
-$260.15 M
|
-$262.60 M
|
-$106.55 M
|
-$406.49 M
|
-$60.05 M
|
-$282.59 M
|
| Net Income Ratio |
-0.07
|
-0.04
|
-0.06
|
-0.04
|
-0.27
|
-0.05
|
-0.36
|
| EPS |
-24.5 |
-15.75 |
-16 |
-6.5 |
-27.25 |
-4 |
-18.5 |
| EPS Diluted |
-24.5 |
-15.75 |
-16 |
-6.5 |
-27.25 |
-4 |
-18.5 |
| Weighted Average Shares Out |
$16.56 M
|
$16.44 M
|
$16.36 M
|
$16.33 M
|
$14.92 M
|
$15.39 M
|
$15.36 M
|
| Weighted Average Shares Out Diluted |
$16.56 M
|
$16.44 M
|
$16.36 M
|
$16.33 M
|
$14.92 M
|
$15.39 M
|
$15.36 M
|
| Link |
|
|
|
|
|
|
|
